FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
| Status: | Completed |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | December 2012 |
| End Date: | May 2014 |
A Proof-of-Concept, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Adenoviral Conjunctivitis
This randomized, double masked, multi-center study is being conducted to support the safety
and efficacy of FST-100 for the treatment of acute adenoviral conjunctivitis.
and efficacy of FST-100 for the treatment of acute adenoviral conjunctivitis.
Inclusion Criteria:
- Have a clinical diagnosis of suspected acute adenoviral conjunctivitis in at least
one eye.
Exclusion Criteria:
- Have a known sensitivity to any of the components of FST-100 or FST-100 vehicle.
We found this trial at
2
sites
